Patent · US Active

Salt forms of a complement component C5A receptor

US11427541B2 · kind B2 · utility

1Cited by

9References

32Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Rajinder Singh · Belmont, US
Kwok YAU · Sunnyvale, US
Yibin Zeng · Foster City, US
Penglie Zhang · Foster City, US
Rebecca M. Lui · Mountain View, US
Ju Yang · Palo Alto, US
Howard S. Roth · Champaign, US

Key dates

Filing date	Nov 6, 2020
Grant date	Aug 30, 2022
Priority date	—
Expiry date	Jan 31, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are salt forms of a complement component 5a receptor having the formula of Compound 1Also provided herein are pharmaceutical compositions and methods of treatment using the salt forms of Compound 1, described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.